Abstract
Over the past two decades, glycosylated nanoparticles (i.e., glyconanoparticles having sugar residues on the surface) received much attention for biomedical applications such as bioassays and targeted drug delivery. This minireview focuses on three aspects: (1) glycosylated gold nanoparticles, (2) glycosylated quantum dots, and (3) glyconanoparticles self-assembled from amphiphilic glycopolymers. The synthetic methods and the multivalent interactions between glyconanoparticles and lectins is shortly illustrated.
Keywords: Glyconanoparticles, glycopolymers, biomolecular recognition, bioassays, targeted drug delivery, multivalent interactions, biological receptors, cell adhesion, carbohydrate-protein interactions, magnetic resonance imaging, colloidal stability, water-solubility, biodegradable, glycopolymer
Combinatorial Chemistry & High Throughput Screening
Title: Glyconanoparticles for Biomedical Applications
Volume: 14 Issue: 3
Author(s): Chang-Ming Dong
Affiliation:
Keywords: Glyconanoparticles, glycopolymers, biomolecular recognition, bioassays, targeted drug delivery, multivalent interactions, biological receptors, cell adhesion, carbohydrate-protein interactions, magnetic resonance imaging, colloidal stability, water-solubility, biodegradable, glycopolymer
Abstract: Over the past two decades, glycosylated nanoparticles (i.e., glyconanoparticles having sugar residues on the surface) received much attention for biomedical applications such as bioassays and targeted drug delivery. This minireview focuses on three aspects: (1) glycosylated gold nanoparticles, (2) glycosylated quantum dots, and (3) glyconanoparticles self-assembled from amphiphilic glycopolymers. The synthetic methods and the multivalent interactions between glyconanoparticles and lectins is shortly illustrated.
Export Options
About this article
Cite this article as:
Dong Chang-Ming, Glyconanoparticles for Biomedical Applications, Combinatorial Chemistry & High Throughput Screening 2011; 14 (3) . https://dx.doi.org/10.2174/138620711794728716
DOI https://dx.doi.org/10.2174/138620711794728716 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Animal Models of Atherosclerosis Progression: Current Concepts
Current Drug Targets - Cardiovascular & Hematological Disorders Mutagenic Approaches to Modifying Gap Junction Phenotype
Current Drug Targets Micro-RNA in Disease and Gene Therapy
Current Drug Discovery Technologies Advances in Lentiviral Vectors: A Patent Review
Recent Patents on DNA & Gene Sequences Cancer Stem Cells in Prostate Cancer Chemoresistance
Current Cancer Drug Targets Medicinal Compound Celastrol As a Potential Clinical Anticancer Drug: Lessons Learned From Preclinical Studies
Clinical Cancer Drugs Molecular Imaging with Nucleic Acid Aptamers
Current Medicinal Chemistry Attacking c-Myc: Targeted and Combined Therapies for Cancer
Current Pharmaceutical Design Inflammation and Cancer: When NF-κB Amalgamates the Perilous Partnership
Current Cancer Drug Targets Caffeic Acid Phenethyl Ester Effects: In Silico Study of its Osteoimmunological Mechanisms
Letters in Drug Design & Discovery The Tumor Stroma as Mediator of Drug Resistance - A Potential Target to Improve Cancer Therapy?
Current Pharmaceutical Biotechnology Tumour Re-Differentiation Effect of Retinoic Acid: A Novel Therapeutic Approach for Advanced Thyroid Cancer
Current Pharmaceutical Design Gene Silencing in the Development of Personalized Cancer Treatment: The Targets, the Agents and the Delivery Systems
Current Gene Therapy SELDI Protein Chip Technology for the Detection of Serum Biomarkers for Liver Disease
Protein & Peptide Letters (Review Article) Screening for Disease-Markers and Investigating Drug Effects by Proteome Profiling: Can it Meet Expectations?
Combinatorial Chemistry & High Throughput Screening Recent Patents on the Identification and Clinical Application of microRNAs and Target Genes
Recent Patents on DNA & Gene Sequences Emergence of Functionalized Nanomedicines in Cancer Chemotherapy: Recent Advancements, Current Challenges and Toxicity Considerations
Recent Patents on Nanomedicine Histone Deacetylase Inhibitors In Inflammatory Disease
Current Topics in Medicinal Chemistry Aspirin Use on Incidence and Mortality of Gastrointestinal Cancers: Current State of Epidemiological Evidence
Current Pharmaceutical Design Cancer: A Problem of Developmental Biology; Scientific Evidence for Reprogramming and Differentiation Therapy
Current Drug Targets